{"schema_version":"secwatch.filing_event.v1","accession":"0000805928-23-000102","form_type":"8-K","ticker":"AXGN","cik":"0000805928","company_name":"Axogen, Inc.","filed_at":"2023-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.686816+00:00","generated_at":"2026-06-11T07:14:47.030093+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Axogen shareholders reject incentive plan share increase at 2023 annual meeting","bullets":["Proposal to increase LTIP shares from 8M to 10.5M failed with 11.3M for vs 18.6M against (excluding broker non-votes).","ESPP share increase (600K to 1.2M) approved with 27.4M for, 2.6M against.","Bylaws amendment to set board size range of 7-11 members approved with 34.1M for, 0.9M against.","All nine director nominees elected; highest withheld was Guido Neels with 7.2M withheld.","Say-on-pay passed with 28.6M for, 1.4M against; auditor ratification approved with 34.9M for."],"urls":{"canonical":"https://secwatch.observer/filing/0000805928-23-000102","json":"https://secwatch.observer/filing/0000805928-23-000102.json","markdown":"https://secwatch.observer/filing/0000805928-23-000102.md","text":"https://secwatch.observer/filing/0000805928-23-000102.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000102/0000805928-23-000102-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000102/axgn-20230815.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T07:14:47.030093+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0998c1c5a662b07d65e51379d39727a6dbe9e3e5","claim":"Axogen, Inc. shareholders approved Election of nine directors to serve for a one-year term until the 2024 annual meeting of shareholders at the 2023-08-15 meeting.","evidence_excerpt":"Nine directors were elected to the Company’s Board of Directors (the \"Board\") to serve for a one-year term until the 2023 annual meeting of shareholders. The results of the election were as follows: Name For Withheld Broker Non-Votes Karen Zaderej 29,010,146 1,124,288 4,943,673 Amy Wendell 29,004,864 1,129,570 4,943,673 William Burke 28,413,152 1,721,282 4,943,673 Gregory Freitag 29,040,709 1,093,725 4,943,673 John H. Johnson 23,637,550 6,496,884 4,943,673 Alan Levine 29,215,878 918,556 4,943,673 Guido Neels 22,945,316 7,189,118 4,943,673 Paul Thomas 28,834,881 1,299,553 4,943,673 Joseph Tyndall, MD MPH, FACEP 29,410,761 723,673 4,943,673","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000102/0000805928-23-000102-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-15"}],"fact_type":"shareholder_vote"},{"claim_id":"09c3c73204617885a5afdc05c5327a93635e75d5","claim":"Axogen, Inc. shareholders approved Advisory (non-binding) vote on executive compensation of named executive officers at the 2023-08-15 meeting.","evidence_excerpt":"For Against Abstentions Broker Non-Votes 28,598,027 1,372,361 164,046 4,943,673","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000102/0000805928-23-000102-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-15"}],"fact_type":"shareholder_vote"},{"claim_id":"3e1ce2c4af39440ef6364580979502b1b04d7bef","claim":"Axogen, Inc. shareholders approved Ratification of Appointment of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2023 at the 2023-08-15 meeting.","evidence_excerpt":"For Against Abstentions Broker Non-Votes 34,923,002 146,443 8,662 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000102/0000805928-23-000102-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-15"}],"fact_type":"shareholder_vote"},{"claim_id":"6a49b61124ab4eaf7ca7c0cddc7d21baf4ded52e","claim":"Axogen, Inc. shareholders approved Amendment and restatement of Axogen, Inc. 2017 Employee Stock Purchase Plan to increase shares from 600,000 to 1,200,000 at the 2023-08-15 meeting.","evidence_excerpt":"For Against Abstentions Broker Non-Votes 27,438,032 2,597,564 98,838 4,943,673","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000102/0000805928-23-000102-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-15"}],"fact_type":"shareholder_vote"},{"claim_id":"90850c593947daad827f01b4f566dbcf041865aa","claim":"Axogen, Inc. shareholders approved Amendment to Bylaws to set Board size range of 7 to 11 members and allow Board to set specific number within that range at the 2023-08-15 meeting.","evidence_excerpt":"For Against Abstentions Broker Non-Votes 34,131,162 865,249 81,696 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000102/0000805928-23-000102-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-15"}],"fact_type":"shareholder_vote"},{"claim_id":"a70ba495dae169994f6133660561856bf8c16fac","claim":"Axogen, Inc. shareholders rejected Amendment and restatement of Axogen, Inc. 2019 Long-Term Incentive Plan to increase shares from 8,000,000 to 10,500,000 at the 2023-08-15 meeting.","evidence_excerpt":"For Against Abstentions Broker Non-Votes 11,294,448 18,612,185 227,801 4,943,673","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000080592823000102/0000805928-23-000102-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2023-08-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}